PolyTechnos Venture Partners is the famous VC, which was founded in 1998. The fund was located in Europe if to be more exact in Germany. The leading representative office of defined VC is situated in the Munich.
This organization was formed by Dirk Kanngiesser. The overall number of key employees were 3.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the PolyTechnos Venture Partners, startups are often financed by Sofinnova Partners, Walden Israel Venture Capital, Eurofund. The meaningful sponsors for the fund in investment in the same round are Walden Israel Venture Capital, Eurofund, Vertex Ventures Israel. In the next rounds fund is usually obtained by Gemini Israel Ventures, Walden Israel Venture Capital, Vertex Ventures Israel.
Opposing the other organizations, this PolyTechnos Venture Partners works on 18 percentage points less the average amount of lead investments. The important activity for fund was in 2006. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2009. Considering the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from PolyTechnos Venture Partners is 10-50 millions dollars.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Electronics. Among the various public portfolio startups of the fund, we may underline Plastic Logic Germany, Addex Therapeutics, NemeriX For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has exact preference in some founders of portfolio startups.
Related Funds
Funds with similar focus
Fund Name | Location |
Acquipharma | - |
Canadian Government | Canada, Ontario, Ottawa |
Dahua Technology | Binjiang, China, Jiangxi |
DIC Corporation | - |
Era Funding Administration | - |
Fellowes | Illinois, Itasca, United States |
Gunosy | Chiba, Japan, Minato |
RATNAAFIN | Ahmedabad, Gujarat, India |
Redbox | Chicago, Illinois, United States |
Renovus Capital Partners | Pennsylvania, United States, Wynnewood |
Rogers Capital | Mauritius, Port Louis, Port Louis |
Rough Diamond Capital | - |
Shenzhen Weixi VC | China, Henan, Zhengzhou |
Soilbuild Group Holdings | Central, Central Region, Singapore |
Technology Venture Partners | Bristol, England, United Kingdom |
Trevi Health Ventures | New York, New York, United States |
Twynam Agricultural Group | Australia, New South Wales, Sydney |
Women Business Angels Club | Belgium, Brabant Wallon, Mont-saint-guibert |
Wooshin Venture Investment Corp. | Seoul, Seoul-t'ukpyolsi, South Korea |
Xinjiang Guanghui Chelianwang Touzi Guanli Youxian Gongsi | China, Ürümqi, Xinjiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cappella Medical Devices | $17M | 22 Jul 2009 | Galway, Galway, Ireland | ||
BiPar Sciences | $20M | 12 Jan 2009 | California, United States | ||
NemeriX | $22M | 17 Sep 2007 | Ticino, Switzerland | ||
Cappella Medical Devices | $7M | 07 Mar 2007 | Galway, Galway, Ireland | ||
BiPar Sciences | $35M | 26 Feb 2007 | California, United States | ||
$7M | 20 Feb 2007 | Israel, North District, Israel | |||
Intelligent Medical Implants Ltd | $17M | 30 Oct 2006 | Zug, Switzerland | ||
Addex Therapeutics | $29M | 19 Sep 2006 | Geneva, Switzerland | ||
Innolume | $9M | 15 Jun 2006 | North Rhine-Westphalia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cappella Medical Devices | $17M | 22 Jul 2009 | Galway, Galway, Ireland | ||
BiPar Sciences | $20M | 12 Jan 2009 | California, United States | ||
NemeriX | $22M | 17 Sep 2007 | Ticino, Switzerland | ||
Cappella Medical Devices | $7M | 07 Mar 2007 | Galway, Galway, Ireland | ||
BiPar Sciences | $35M | 26 Feb 2007 | California, United States | ||
$7M | 20 Feb 2007 | Israel, North District, Israel | |||
Intelligent Medical Implants Ltd | $17M | 30 Oct 2006 | Zug, Switzerland | ||
Addex Therapeutics | $29M | 19 Sep 2006 | Geneva, Switzerland | ||
Innolume | $9M | 15 Jun 2006 | North Rhine-Westphalia |